The company has issued voluntary recall of one batch of Metformin extended release tablets (USP 500 mg) due to detection of NDMA (N-nitrosodimethylamine), Marksans Pharma said in a regulatory filing.from Moneycontrol Business News https://ift.tt/3cC0968
No comments:
Post a Comment